- Home
- ICCC vs ALVR Comparison
ICCC vs ALVR Comparison
Compare ICCC & ALVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- ALVR
- Stock Information
- Founded
- ICCC 1982
- ALVR 2013
- Country
- ICCC United States
- ALVR United States
- Employees
- ICCC N/A
- ALVR N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ICCC Health Care
- ALVR Health Care
- Exchange
- ICCC Nasdaq
- ALVR Nasdaq
- Market Cap
- ICCC 45.9M
- ALVR 46.6M
- IPO Year
- ICCC 1987
- ALVR 2020
- Fundamental
- Price
- ICCC $5.11
- ALVR $9.20
- Analyst Decision
- ICCC
- ALVR
- Analyst Count
- ICCC 0
- ALVR 0
- Target Price
- ICCC N/A
- ALVR N/A
- AVG Volume (30 Days)
- ICCC 10.1K
- ALVR 31.5K
- Earning Date
- ICCC 02-25-2025
- ALVR 03-14-2025
- Dividend Yield
- ICCC N/A
- ALVR N/A
- EPS Growth
- ICCC N/A
- ALVR N/A
- EPS
- ICCC N/A
- ALVR N/A
- Revenue
- ICCC $23,838,001.00
- ALVR N/A
- Revenue This Year
- ICCC N/A
- ALVR N/A
- Revenue Next Year
- ICCC N/A
- ALVR N/A
- P/E Ratio
- ICCC N/A
- ALVR N/A
- Revenue Growth
- ICCC 46.37
- ALVR N/A
- 52 Week Low
- ICCC $3.34
- ALVR $7.96
- 52 Week High
- ICCC $5.82
- ALVR $24.15
- Technical
- Relative Strength Index (RSI)
- ICCC 52.70
- ALVR 37.99
- Support Level
- ICCC $4.86
- ALVR $7.96
- Resistance Level
- ICCC $5.50
- ALVR $10.00
- Average True Range (ATR)
- ICCC 0.36
- ALVR 1.14
- MACD
- ICCC -0.03
- ALVR 0.04
- Stochastic Oscillator
- ICCC 39.06
- ALVR 31.00
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.